Statements (60)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:legal_case
|
| gptkbp:advocates_for |
informed consent required
|
| gptkbp:allows |
limited to specific population
|
| gptkbp:analysis |
statistical analysis
|
| gptkbp:analyzes |
Dr. Andreas Zeller
|
| gptkbp:business_model |
adhered to ethical standards
obtained from ethics committee |
| gptkbp:clinical_trial |
2 years
high relevance to cardiology registered with WHO |
| gptkbp:collaborations |
with academic institutions
international research networks various hospitals in Germany |
| gptkbp:collection |
2 years
clinical assessments |
| gptkbp:complications |
important for treatment decisions
|
| gptkbp:criteria |
diagnosed with acute coronary syndrome
previous myocardial infarction |
| gptkbp:end_date |
gptkb:2003
|
| gptkbp:events |
1 year
|
| gptkbp:focus |
acute coronary syndrome
|
| gptkbp:followed_by |
assessed at 5 years
|
| gptkbp:future_plans |
recommended in broader populations
|
| https://www.w3.org/2000/01/rdf-schema#label |
ISAR-TEST trial
|
| gptkbp:is_compared_to |
standard treatment
|
| gptkbp:is_protected_by |
antiplatelet therapy
|
| gptkbp:is_studied_in |
completed successfully
multicenter study |
| gptkbp:is_tested_for |
Phase III
|
| gptkbp:launch_date |
gptkb:2001
|
| gptkbp:location |
gptkb:government_agency
|
| gptkbp:participants |
over 2000
mortality rate quality of life assessments myocardial infarction rate |
| gptkbp:population |
diverse age groups
|
| gptkbp:provides_information_on |
influenced treatment guidelines
data available upon request |
| gptkbp:published_by |
gptkb:The_Lancet
|
| gptkbp:receives_funding_from |
public and private funding
grants from health organizations |
| gptkbp:recruitment |
conducted in multiple centers
|
| gptkbp:registration |
gptkb:Clinical_Trials.gov
|
| gptkbp:reports_to |
transparent and thorough
|
| gptkbp:research |
randomized controlled trial
published in peer-reviewed journals presented at conferences contributed to medical knowledge rigorous and systematic |
| gptkbp:research_focus |
cardiovascular health
|
| gptkbp:result |
improved outcomes in patients
|
| gptkbp:safety_features |
prioritized throughout study
|
| gptkbp:scientific_goals |
improve patient outcomes
|
| gptkbp:side_effect |
monitored throughout study
|
| gptkbp:significance |
p<0.05 considered significant
|
| gptkbp:sponsor |
German Heart Center Munich
|
| gptkbp:student_enrollment |
adults with acute coronary syndrome
|
| gptkbp:treatment |
standardized across sites
|
| gptkbp:bfsParent |
gptkb:Xience_drug-eluting_stent
|
| gptkbp:bfsLayer |
7
|